18:18 IST
NSE
Other Announcement
Sun Pharmaceutical Industries Other Announcement
Sun Pharmaceutical informed the exchanges that its board meeting concluded on July 31, 2026, after adjourning for a break during the session.
Sun Pharmaceutical Industries Ltd
- Share price
- ₹1,781.00
- Market cap
- ₹4,27,322 Cr
- Revenue (annual)
- ₹58,462 Cr
- Net profit (annual)
- ₹11,479 Cr
- P/E (TTM)
- 35.3×Sector 47.4×
- Promoter holding
- 54.48%+0.00% QoQ
- FII holding
- 14.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 9Annual General Meeting 8Financial Results 5Promoter Reclassification 4Other Announcement 4Management Change 4Merger & Restructuring 3Credit Rating 3Acquisition 3Legal & Regulatory 2Business Update 2Board Meeting Date 2Regulatory Approval 1Price Movement Clarification 1Dividend 1Board Meeting Outcome 1Annual Report 1
Time
4 announcements with these filters
11:44 IST
BSE
Other Announcement
Sun Pharmaceutical Industries Other Announcement
Sun Pharma's independent director Mr. Gautam Doshi has been arrested in an unrelated matter. The company sees no impact on its operations or board.
18:24 IST
NSE
Other Announcement
Sun Pharmaceutical Industries Other Announcement
Sun Pharma will present long-term follow-up data for UNLOXCYT at the ASCO 2026 meeting. The study shows durable responses and a manageable safety profile for laCSCC patients.
16:54 IST
BSE
Other Announcement
Sun Pharmaceutical Industries Other Announcement
Sun Pharmaceutical Industries Ltd submitted its quarterly confirmation certificate for the period ended March 31, 2026, regarding the dematerialisation of securities. The registrar, MUFG Intime India, confirmed compliance with SEBI (Depositories and Participants) Regulations. This is a routine administrative filing with no material impact on business operations.